Navigation Links
DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Latest Defense Motion in Federal DePuy ASR Recall Litigation

New York, New York (PRWEB) August 21, 2013

The federal multidistrict litigation established for DePuy ASR hip lawsuits ( continues to move towards the commencement of its first bellwether trial, Bernstein Liebhard LLP reports. According to a Motion filed with the U.S. District Court, Northern District of Ohio on August 5th, DePuy Orthopaedics has requested that the Court subject punitive damage claims put forth in the bellwether case to the laws of Indiana and the United Kingdom, the defendants’ home jurisdictions. The DePuy ASR lawsuit is scheduled to go to trial on September 9, 2013. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

“This case will be one of several important trials to get underway this fall in the various litigations established in the wake of the August 2010 DePuy ASR recall. Our Firm is looking forward to this trial, as well as other scheduled in state proceedings underway in New Jersey and California,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices, including hundreds of clients in DePuy ASR lawsuits. The Firm continues to offer free legal evaluations to anyone who suffered serious complications associated with the DePuy ASR recall.

DePuy ASR Lawsuits
According to court documents, more than 11,000 product liability claims have been filed in courts around the country since the DePuy ASR recall was announced three years ago. Just over 7,800 of those lawsuits are pending in the Northern District of Ohio, where Bernstein Liebhard LLP is actively filing claims. Following the commencement of the bellwether trial in the federal proceeding, a bellwether trial of DePuy ASR lawsuit in a consolidated litigation pending in California Superior Court is scheduled to begin on October 1, 2013. (DePuy ASR HIP System Cases, No. CJC-10-004649; Calif. Super. Ct., San Francisco Cty.) A bellwether trial is also slated to get underway on October 21, 2013 in a Multicounty Litigation that has been established for DePuy ASR lawsuits in New Jersey Superior Court. (In Re DePuy ASR Hip Implants Litigation, BER-L-3971-11)

Earlier this year, trials concluded in two other state claims involving the DePuy ASR recall. In March, a plaintiff was awarded more than $8 million after a Los Angeles Superior Court jury found that the hip implant was defectively designed. (Kransky v. DePuy, BC456086, California Superior Court, Los Angeles County) However, a jury in Chicago found for Johnson & Johnson in a second trial just one month later. (Strum v. DePuy, 2011-L-9352, Circuit Court of Cook County).

According to the U.S. Food & Drug Administration (FDA), the DePuy ASR recall was issued after data from a United Kingdom joint registry indicated that the 5 year revision rate associated with the metal-on-metal hip implants was approximately 13 percent. In February 2011, the FDA began a safety review of all-metal hips amid concerns that such devices could shed dangerous amounts of metal ions into the tissue surrounding the hip and the blood stream, leading to pain, swelling, metallosis, and premature device failure. In January the agency urged patients with such devices to undergo metal ion blood tests if they experienced any symptoms that would signify a failing hip implant. The FDA has also proposed a new rule which would subject such devices to greater regulatory oversight.*

Individuals who have suffered serious complications allegedly associated with a DePuy ASR hip may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. Read More about filing a DePuy ASR lawsuit at Bernstein Liebhard LLP’s website. For a free case review, please contact one of our attorneys by calling 800-511-5092.


About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy ASR Lawsuit Update: Rottenstein Law Group LLP Responds to J&J $3 Billion Settlement Report
2. Possible August 2013 Deadline Ahead for North Carolina DePuy ASR Hip Recall Lawsuits, Product Liability Lawyer Ben Cochran Says
3. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Most Recent Developments in New Jersey DePuy ASR Recall Litigation
4. Plaintiff Furnishes Witness List for First Trial in DePuy ASR Multidistrict Litigation, Reports Parker Waichman LLP
5. US Drug Watchdog Urges Recalled DePuy ASR Hip Implant Recipients To Call Them Immediately If They Live In A State Where The Statute Of Limitations Has Not Yet Run Out
6. New DePuy Metal Hip Implant Lawsuits Allegations Update: Resource4thePeople Reports Important Trial Scheduled in Federal Consolidated Cases
7. DePuy ASR Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Pre-trial Ruling in Federal DePuy ASR Recall Litigation
8. DePuy ASR Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Release of New Pretrial Order in New Jersey DePuy ASR Recall Litigation
9. DePuy ASR Lawsuit News: Rottenstein Law Group LLP Comments on Judge’s Decision to Exclude 2010 ASR Recall from Trial
10. DePuy Pinnacle Hip Lawsuit Filings in Federal Multidistrict Litigation Exceed 4,600, Bernstein Liebhard LLP Reports
11. DePuy Hip Class I Recall Announced By FDA of Its DePuy LPS Lower Extremity Dovetail Intercalary Hip Implant Component Due to Risk of Fracturing, Reports Wright & Schulte
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... Dental Association meeting in Washington D.C. revolved around the fact that proper dental care, ... The talk stressed the link between periodontal disease (more commonly referred to as gum ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... and convenient way to dispense prescription medications at home, so he invented the ... to monitor and dispense prescription medications. In doing so, it could help to ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that ... ). More than 3.7 billion people under the age of 50 – or 67% ... WHO's first global estimates of HSV-1 infection . , "The data shocks us highly!" ...
(Date:11/27/2015)... ... 2015 , ... Keeping in mind challenges faced by parents ... consultation, has collaborated with a leading web-based marketplace for extra-curricular activities for children ... and bring advice from parenting experts within their reach. As a part of ...
(Date:11/27/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk ... Term Support) into its Q-Suite 5.10 product line. , Making the change to ... of Asterisk that will receive not only security fixes, but feature and bug ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... WASHINGTON , Nov. 25, 2015  The ... Obstetricians and Gynecologists (ACOG), and the March of ... bipartisan Protecting Our Infants Act of 2015 ... the number of newborns born exposed to drugs, ... Since the bill,s introduction, all three organizations have ...
(Date:11/25/2015)... Nov. 25, 2015 On Tuesday, November ... bellwether trial against Wright Medical Technology, Inc. for ... Conserve metal-on-metal hip implant device, awarded $11 million ... two week trial and three days of deliberations, ... device was defectively designed and unreasonably dangerous, and ...
(Date:11/25/2015)... Israel , November 25, 2015 ... KTOV ) (TASE: KTOV), a biopharmaceutical company focused ... treatment of various clinical conditions, today announced the closing ... American Depository Shares ( ADSs ), each representing 20 ... up to 3,158,900 ADSs. The ADSs and warrants were ...
Breaking Medicine Technology: